[go: up one dir, main page]

AU2001285047A1 - Human genes and gene expression products - Google Patents

Human genes and gene expression products

Info

Publication number
AU2001285047A1
AU2001285047A1 AU2001285047A AU8504701A AU2001285047A1 AU 2001285047 A1 AU2001285047 A1 AU 2001285047A1 AU 2001285047 A AU2001285047 A AU 2001285047A AU 8504701 A AU8504701 A AU 8504701A AU 2001285047 A1 AU2001285047 A1 AU 2001285047A1
Authority
AU
Australia
Prior art keywords
gene expression
expression products
human genes
genes
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001285047A
Other languages
English (en)
Inventor
Jaime Escobedo
Pablo Dominguez Garcia
Altaf Kassam
Ivan Labat
George Lamson
David Pot
Filippo Randazzo
Christoph Reinhard
Elizabeth M. Scott
Julie Sudduth-Klinger
Guozhong Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Hyseq Inc
Original Assignee
Hyseq Inc
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Chiron Corp filed Critical Hyseq Inc
Publication of AU2001285047A1 publication Critical patent/AU2001285047A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001285047A 2000-08-16 2001-08-16 Human genes and gene expression products Abandoned AU2001285047A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22632600P 2000-08-16 2000-08-16
US60/226,326 2000-08-16
PCT/US2001/025840 WO2002014500A2 (fr) 2000-08-16 2001-08-16 Genes humains et produits d'expression genique

Publications (1)

Publication Number Publication Date
AU2001285047A1 true AU2001285047A1 (en) 2002-02-25

Family

ID=22848480

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001285047A Abandoned AU2001285047A1 (en) 2000-08-16 2001-08-16 Human genes and gene expression products

Country Status (5)

Country Link
US (1) US20070243176A1 (fr)
EP (1) EP1309679A2 (fr)
JP (1) JP2004512029A (fr)
AU (1) AU2001285047A1 (fr)
WO (1) WO2002014500A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001281197A1 (en) * 2000-08-09 2002-02-18 Millennium Pharmaceuticals, Inc. A human adenylate kinase family member and uses therefor
AU2002243444A1 (en) * 2000-10-31 2002-06-24 Diadexus, Inc. Compositions and methods relating to colon specific genes and proteins
AU2002245371A1 (en) * 2001-01-31 2002-08-12 Millennium Pharmaceuticals, Inc. Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
US7041643B2 (en) 2001-01-31 2006-05-09 Millennium Pharmaceuticals, Inc. Molecules of the PYRIN/NBS/LRR protein family and uses thereof
EP1534855B1 (fr) 2002-06-25 2010-12-08 Index Diagnostics AB (publ) Procede et kit pour diagnostic de colite ulcereuse
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US20090252721A1 (en) * 2003-09-18 2009-10-08 Thomas Buschmann Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
EP1744162B1 (fr) 2004-03-31 2010-08-04 Hiroyuki Aburatani Diagnostic du cancer et traitement utilisant l'anticorps anti-robo1
WO2005100998A2 (fr) * 2004-04-16 2005-10-27 Europroteome Ag Marqueurs membranaires destines a etre utilises pour le diagnostic et le traitement du cancer
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
JP5302012B2 (ja) 2006-03-08 2013-10-02 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤
EP2049518B1 (fr) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Derives de l'indazole et de l'isoindazole comme agents de l'activation de glucokinase
WO2008065637A1 (fr) * 2006-12-01 2008-06-05 University College York - National University Of Ireland, Cork Traitement de la maladie
WO2008079787A2 (fr) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Activateurs de glucokinase
EP2135080A4 (fr) * 2007-03-08 2010-12-01 Switchgear Genomics Reseaux fonctionnels pour la caracterisation de traitement d'elements de regulation dans des regions non traduites de genes
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
JP5117765B2 (ja) 2007-05-28 2013-01-16 国立大学法人 東京大学 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤
CA2770888C (fr) 2009-08-31 2020-04-14 Gen-Probe Incorporated Essai du virus de la dengue
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
ES2720763T3 (es) 2012-06-27 2019-07-24 Berg Llc Uso de marcadores en el diagnóstico y tratamiento de cáncer de próstata
RU2678127C2 (ru) 2012-11-13 2019-01-23 Бионтех Аг Агенты для лечения экспрессирующих клаудин раковых заболеваний
CN104535511A (zh) * 2014-07-04 2015-04-22 陶淑芳 基于单酶反应的l-谷氨酰胺的比色测定方法以及测定试剂盒
CN107428821B (zh) 2014-12-08 2022-06-24 博格有限责任公司 包括细丝蛋白a的标志物在诊断和治疗前列腺癌中的用途
JOP20190025A1 (ar) * 2016-09-01 2019-02-19 Denovo Biopharma Llc طرق وتركيبة لتوقع نشاط إنزاستورين

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5357617A (en) * 1991-11-22 1994-10-18 International Business Machines Corporation Method and apparatus for substantially concurrent multiple instruction thread processing by a single pipeline processor
US5983339A (en) * 1995-08-21 1999-11-09 International Business Machines Corporation Power down system and method for pipelined logic functions
US5778246A (en) * 1995-12-27 1998-07-07 Intel Corporation Method and apparatus for efficient propagation of attribute bits in an instruction decode pipeline
US6026476A (en) * 1996-03-19 2000-02-15 Intel Corporation Fast fully associative translation lookaside buffer
US5890008A (en) * 1997-06-25 1999-03-30 Sun Microsystems, Inc. Method for dynamically reconfiguring a processor
US5913049A (en) * 1997-07-31 1999-06-15 Texas Instruments Incorporated Multi-stream complex instruction set microprocessor
US6476207B1 (en) * 1998-06-11 2002-11-05 Chiron Corporation Genes and gene expression products that are differentially regulated in prostate cancer
US6385719B1 (en) * 1999-06-30 2002-05-07 International Business Machines Corporation Method and apparatus for synchronizing parallel pipelines in a superscalar microprocessor
US6357016B1 (en) * 1999-12-09 2002-03-12 Intel Corporation Method and apparatus for disabling a clock signal within a multithreaded processor

Also Published As

Publication number Publication date
JP2004512029A (ja) 2004-04-22
WO2002014500A3 (fr) 2003-03-06
EP1309679A2 (fr) 2003-05-14
WO2002014500A2 (fr) 2002-02-21
US20070243176A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
AU2001245619A1 (en) Human genes and gene expression products
AU2001285047A1 (en) Human genes and gene expression products
AU6069300A (en) Novel human genes and gene expression products
AU4053699A (en) Novel human genes and gene expression products
AU4187499A (en) Human genes and gene expression products v
AU2001249125A1 (en) Human fgf-23 gene and gene expression products
AU2095599A (en) Human genes and gene expression products i
AU2001245535A1 (en) Human fgf-23 gene and gene expression products
AU2002230591A1 (en) Genes associated with mechanical stress, expression products therefrom, and uses thereof
AU2002365077A1 (en) Methods and products related to non-viral transfection
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU2002327607A1 (en) Human genes and gene expression products isolated from human prostate
AU4329300A (en) Human mesenchymal dnas and expression products
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU2001288061A1 (en) Drug resistance-associated gene and use thereof
AU1101901A (en) Human fgf-20 gene and gene expression products
AU6263999A (en) Human genes and gene expression products
AU2001226922A1 (en) Cancer associated genes and their products
AU2002229113A1 (en) Glucose transport-related genes and uses thereof
AU2001287269A1 (en) Human genes and expression products
AU2001270478A1 (en) Gene expression in biological conditions
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU6773200A (en) Egfh2 genes and gene products
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof